LY2623091 [1162264-07-4]

TargetMol Chemicals

LY2623091 [1162264-07-4]

9

Research Use Only

C30H30FN5O3

527.59

LY2623091, a mineralocorticoid receptor antagonist, is utilized in treating refractory hypertension. It demonstrates CYP3A4-dependent clearance and exhibits synergistic effects when combined with CYP3A4 inhibitors.

C(=C\1/C=2C(OCC=3C1=CC=CC3)=CC(F)=CC2)\C=4C=C5C(=CC4)N([C@@H](CN6CCOCC6)C)C(NC(N)=O)=N5

-20°C

12352200